Comparison of Serum Magnesium Levelin Diabetes Mellitus (DM) Patientswith or without Acute Coronary Syndrome (ACS)

Article history: Received 19 September 2019 Received in revised form 23 October 2019 Accepted 25 October 2019 Available online 31 October 2019

[1]  W. Sheu,et al.  Glycated hemoglobin level is an independent predictor of major adverse cardiac events after nonfatal acute myocardial infarction in nondiabetic patients , 2017, Medicine.

[2]  A. B. Hartopo,et al.  The Prevalence and Impact of Body Mass Index Category in Patients with Acute Myocardial Infarction , 2017 .

[3]  Alejandro Lucia,et al.  Epidemiology of coronary heart disease and acute coronary syndrome. , 2016, Annals of translational medicine.

[4]  G. Walton,et al.  A Vicious Cycle , 2016, Perspectives on psychological science : a journal of the Association for Psychological Science.

[5]  Brenda C T Kieboom,et al.  Serum Magnesium and the Risk of Death From Coronary Heart Disease and Sudden Cardiac Death , 2016, Journal of the American Heart Association.

[6]  J. Hoenderop,et al.  Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? , 2015, Diabetes.

[7]  A. Tamer,et al.  Associations of serum Magnesium levels with diabetes mellitus and diabetic complications. , 2015, Hippokratia.

[8]  A. Catena,et al.  Body mass index and myocardium at risk in patients with acute coronary syndrome. , 2014, Revista clinica espanola.

[9]  S. Mahajan,et al.  Significance of serum magnesium levels in reference to acute myocardial infarction and role of intravenous magnesium therapy in prevention of cardiac arrhythmias following myocardial infarction , 2013 .

[10]  Jeffrey M. Miller,et al.  Hypomagnesemia in patients with type 2 diabetes. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[11]  K. Alhabib,et al.  Age and its relationship to acute coronary syndromes in the Saudi Project for Assessment of Coronary Events (SPACE) registry: The SPACE age study. , 2012, Journal of the Saudi Heart Association.